Access Bio, Inc. (KOSDAQ:950130)

South Korea · Delayed Price · Currency is KRW

2,160.00

-80.00 (-3.57%)

Oct 12, 2026, 3:30 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Manufacturing and Selling in Vitro Diagnostic Kits			348.64B	1.03T	505.11B	121.80B	43.06B
Total			348.64B	1.03T	505.11B	121.80B	43.06B

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Africa			1.22B	758.78M	6.70B	12.45B	27.93B
America			331.35B	813.03B	446.54B	79.37B	749.25M
Asia			13.72B	30.37B	30.41B	18.28B	9.27B
Europe			37.25M	107.31M	1.51B	1.40B	3.60B
Oceania			4.93M	162.12B	40.57B	826.38M	1.10B
Total			346.33B	1.01T	525.74B	112.32B	42.65B